Press Releases Circio Holding ASA

Equities

TRVX

NO0013033795

Real-time Oslo Bors Other stock markets 10:45:00 2024-04-30 am EDT			5-day change	1st Jan Change
2.5 ^NOK	+4.17%		-4.58%	-65.28%

Apr. 25	Circio Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 17	Circio Establishes In Vivo Proof-of-Concept for Circular RNA Platform	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds	Apr. 29	AQ
Circio : Annual Report 2023 Report	Apr. 25	PU
Circio Holding ASA: Annual Report 2023	Apr. 25	AQ
Circio Holding ASA: Requested Conversion of Convertible Bonds	Apr. 25	AQ
Circio : Company update 17 April 2024	Apr. 17	PU
Circio announces in vivo proof-of-concept for its circVec circular RNA platform technology and reinforced gene therapy focus	Apr. 17	AQ
Circio announces intention to raise around NOK 50-60 million in Q2 2024 to extend cash runway to Q2 2025	Apr. 17	AQ
Circio terminates TG01 cancer vaccine license option agreement with IOVaxis in China for non-payment	Apr. 17	AQ
Circio Holding ASA: Requested Conversion of Convertible Bonds	Mar. 21	PU
Circio announces that partner IOVaxis Therapeutics has exercised the option for an exclusive license to mutant RAS cancer vaccine TG01 in China	Mar. 19	AQ
Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds	Mar. 13	AQ
Circio Holding ASA: Approval and publication of prospectus	Mar. 08	AQ
Circio : The TG01 IND application by Circio’s partner IOVaxis Therapeutics has been approved by the Chinese regulatory authorities	Mar. 04	PU
The TG01 IND application by Circio's partner IOVaxis Therapeutics has been approved by the Chinese regulatory authorities	Mar. 04	AQ
Circio Holding ASA: Requested Conversion of Convertible Bonds	Mar. 04	AQ
Circio to participate in the Annual European Life Sciences CEO Forum in Zürich	Feb. 27	AQ
Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds	Feb. 07	AQ
Circio Holding ASA: Requested Conversion of Convertible Bonds	Feb. 05	AQ
The first patient has been dosed in Circio's TG01 triple combination study	Feb. 01	AQ
Circio receives waiver of EUR 6.2 million in loans from Business Finland	Jan. 18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Circio Holding ASA

Equities

TRVX

NO0013033795

Press Releases

Filters